Skip to main content
 

Events

The National Institutes of Health (NIH) campuses host a variety of events that inform, challenge, and unite the biomedical research community. IRP investigators lead or participate in many of these events, and they regularly present their work at scientific conferences at the NIH and around the world. We invite you to learn about (and possibly join us in) some of our upcoming events:

Thursday, February 14, 2013, 8:30 am to Friday, February 15, 2013, 6:00 pm

Natcher, Building 45

NIDDK is hosting a workshop, “Urologic Complications of Diabetes: Developing a Basic Research Strategy.” The intent of this conference is to provide a state-of-the-science overview on the effects of diabetes on cellular systems relevant to urologic complications: smooth muscle, autonomic nervous system, endothelium, and vasculature, and to discuss how this knowledge can be leveraged for urologic research. Speakers and participants will discuss how best to integrate the basic science expertise and knowledge with clinical urology expertise to identify basic research priorities. See http://www2.niddk.nih.gov/News/Calendar/urologic2013.htm for the full schedule.

Friday, February 15, 2013, 12:00 pm to 1:00 pm

 Lipsett Amphitheater, NIH Clinical Center (Bldg. 10)

“Deciphering Human Disease Mechanism from Protein Networks: Ciliopathies, Cancer, and Sonic Hedgehog Signaling,” by Peter K. Jackson, Ph.D., Director of Cell Regulation, Staff Scientist, Research Oncology, Genentech, Inc.

Tuesday, February 19, 2013, 4:00 pm to 5:30 pm

Building 50, ground floor auditorium

The 2013 Demystifying Medicine course continues with a presentation by Rafael de Cabo, Ph.D. (NIA) and Jay Chung, M.D./Ph.D. (NHLBI).  The topic is “Preventing Aging.”  Refer to http://demystifyingmedicine.od.nih.gov for course material and other information.  Demystifying Medicine is an annual course from January to May designed to help bridge the gap between advances in biology and their application to major human diseases.  The course includes presentation of patients, pathology, diagnosis, and therapy in the context of major disease problems and current research, primarily directed toward Ph.D. students, fellows, and staff.  All are invited.

Wednesday, February 20, 2013, 12:00 pm to 1:00 pm

Lipsett Amphitheater, NIH Clinical Center (Bldg. 10)

“Psychiatric Symptoms in a Patient with HIV: Co-morbidity or a Symptom of NeuroHIV?,” by Saud Kapetanovic, M.D., Associate Deputy Clinical Director, Office of the Clinical Director, NIMH; and “P-glycoprotein Function and Neuroinflammation in HIV Infection of the Brain,” by William C. Kreisl, M.D., Assistant Clinical Investigator, Molecular Imaging Branch, NIMH.

Wednesday, February 20, 2013, 12:00 pm to 1:00 pm

NCI at Frederick, Md., Building 549

NCI’s Giorgio Trinchieri will present a lecture, “Microbiota and Immunity: Relevance for Tumor Therapy."  This will not be videocast.  Trinchieri’s research at the CCR focuses on the interplay between inflammation/innate resistance and adaptive immunity, and the role of pro-inflammatory cytokines in the regulation of hematopoiesis, innate resistance, and immunity.  He discovered interleukin-12 while at the Wistar Institute in 1989 and for many years has been characterizing the molecular mechanisms of interleukin-12 production and action, and the role of this molecule in tumor immunity, infections, and autoimmunity.

Friday, February 22, 2013, 12:00 pm to 1:00 pm

 Lipsett Amphitheater, NIH Clinical Center (Bldg. 10)

“IRF4: An Unexpected Journey,” by Arthur L. Shaffer III, Ph.D., Staff Scientist, Molecular Biology of Lymphoid Malignancies Section, Metabolism Branch, Center for Cancer Research, NCI.

Tuesday, February 26, 2013, 4:00 pm to 5:30 pm

Building 50, ground floor auditorium

The 2013 Demystifying Medicine course continues with a presentation by Christine Grady, Ph.D. (CC).  The topic is “Ethics and Translational Medicine.”  Refer to http://demystifyingmedicine.od.nih.gov for course material and other information.  Demystifying Medicine is an annual course from January to May designed to help bridge the gap between advances in biology and their application to major human diseases.  The course includes presentation of patients, pathology, diagnosis, and therapy in the context of major disease problems and current research, primarily directed toward Ph.D. students, fellows, and staff.  All are invited.

Wednesday, February 27, 2013, 12:00 pm to 1:00 pm

Lipsett Amphitheater, NIH Clinical Center (Bldg. 10)

“How Can We Identify and Address Social Determinants of Obesity? Lessons from Dallas County, Texas,” by Tiffany M. Powell-Wiley, M.D., M.P.H., Assistant Clinical Investigator, Cardiovascular and Pulmonary Branch, Division of Intramural Research, NHLBI and Applied Research Program, Division of Cancer Control and Population Sciences, NCI; and “The Potential for Glycated Albumin to Replace A1C in African Descent Populations,” by Anne E. Sumner, M.D., Tenured-Investigator and Chief, Section on Ethnicity and Health, Diabetes, Endocrinology and Obesity Branch, NIDDK.

Thursday, February 28, 2013, 8:30 am to 5:00 pm

Natcher, Building 45

The 16th US-Japan Conference on Potential Applications of Mesenchymal Multipotent Stromal Cells is jointly organized by the FDA Center for Biologics Evaluation and Research (CBER) and the Japanese Ministry of Education, Culture, Sports, Science and Technology under the US–Japan Cooperative Research Program.  The goal of the conference is to exchange ideas on cutting edge areas of biomedical research and to enhance opportunities for collaborations among scientists from the U.S. and Japan.  The broad theme of this year's meeting is potential applications of mesenchymal multipotent stromal cells.  Six speakers from Japan and five from the U.S. will discuss the advances in this exciting field of regenerative medicine research.  Contact Syed R Husain at syed.husain@fda.hhs.gov for more information.

Thursday, February 28, 2013, 1:00 pm to 2:00 pm

Lipsett Amphitheater, NIH Clinical Center (Bldg 10)

The next Translational Research Interest Group (TRIG) seminar lecture is “Therapeutic Development Approaches at the National Institute of Neurological Disorders and Stroke” by Rajesh Ranganathan, director of the NINDS Office of Translational Research.

The NINDS Office of Translational Research has five funding programs that aim to provide a breadth of opportunities for academic investigators and small businesses to engage in the spectrum of work, beginning with assay development through to initial test of clinical candidate in human trials.  These are: Epilepsy drug discovery Anti-convulsant Screening Program (ASP); Counter Agents against chemical threats (CounterACT); Blueprint Neurotherapeutics (a virtual pharma network); the SBIR (Small Business Innovation Research) Program; and the U01 Cooperative Translational Research Program (a milestone-driven funding mechanism).  The emerging priorities of the NINDS OTR office are to: ensure that therapeutic development is partnered with the development of mechanistic biomarkers; facilitate deeper understanding of the mechanism of action of the therapeutic candidate, for example by the greater use of imaging; encourage work on diseases that do not have predictive animal models of efficacy; and explore the use phase 0 clinical trials via exploratory Investigational New Drug (eIND) route.  Additionally, there will be emphasis going forward on engaging other stakeholders, such as pharma, biotech, venture capital, and patient organizations to ensure that projects in the office's portfolio have been appropriately de-risked to ensure downstream investments, which will accelerate getting the much-needed therapies to patients suffering from neurological disorders.